兴齐眼药:24Q3费用显著收窄,阿托品完成完整随访实验
关注阿托品滴眼液放量 2024-4-29 兴齐眼药( [Table_StockNameRptType] 300573.SZ) 公司点评 | --- | --- | --- | |-----------------------------------------------------------------------------------|--------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...